Mutations of the BRAF gene in human cancer

Nature

Volumn 417, Issue 6892, 2002, Pages 949-954

  Davies, Helen ^a   Bignell, Graham R ^a   Cox, Charles ^a   Stephens, Philip ^a   Edkins, Sarah ^a   Clegg, Sheila ^a   Teague, Jon ^a   Woffendin, Hayley ^a   Garnett, Mathew J ^b   Bottomley, William ^a   Davis, Neil ^a   Dicks, Ed ^a   Ewing, Rebecca ^a   Floyd, Yvonne ^a   Gray, Kristian ^a   Hall, Sarah ^a   Hawes, Rachel ^a   Hughes, Jaime ^a   Kosmidou, Vivian ^a   Menzies, Andrew ^a   Mould, Catherine ^a   Parker, Adrian ^a   Stevens, Claire ^a   Watt, Stephen ^a   Hooper, Steven ^b   Jayatilake, Hiran ^b   Gusterson, Barry A ^c   Cooper, Colin ^c   Shipley, Janet ^c   Hargrave, Darren ^c   Pritchard Jones, Katherine ^c   Maitland, Norman ^d   Chenevix Trench, Georgia ^e   Riggins, Gregory J ^f   Bigner, Darell D ^f   Palmieri, Giuseppe ^g   Cossu, Antonio ^h   Flanagan, Adrienne ⁱ   Nicholson, Andrew ^j   Ho, Judy W C ^k   Leung, Suet Y ^k   Yuen, Siu T ^k   Weber, Barbara L ^l   Seigler, Hilliard F ^f   Darrow, Timothy L ^f   Paterson, Hugh ^b   Wooster, Richard ^a,c   Stratton, Michael R ^a,b   Futreal, P Andrew ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g CNR   (Italy)

^h UNIVERSITY OF SASSARI   (Italy)

ⁱ ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^j ROYAL BROMPTON HOSPITAL   (United Kingdom)

^k UNIVERSITY OF HONG KONG   (Hong Kong)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; ENZYMES; GENES;

MUTATIONS;

ONCOLOGY;

CANCER; GENE; MUTATION;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE MUTATION; MALIGNANT NEOPLASTIC DISEASE; MISSENSE MUTATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MELANOMA; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; TUMOR CELLS, CULTURED;

EID: 18444374405     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature00766     Document Type: Article

References (24)

1. The Raf/MEK/ERK pathway: New concepts of activation
2. Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade
3. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
4. Genetic alterations during colorectal-tumour development
5. N-ras mutations in human cutaneous melanoma from sun-exposed body sites
6. Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumours
7. The specificity of p53 mutation spectra in sunlight induced human cancers
8. The regulation of normal melancyte proliferation
9. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes
10. The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases
11. Role of the glycine triad in the ATP-binding site of cAMP-dependent protein kinase
12. Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase
13. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor
14. Expression of a novel form of the fyn proto-oncogene in hematopoietic cells
15. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
16. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases
17. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
18. Increasing complexity of the Ras signalling pathway
19. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
20. Cellular ras activity and tumour cell proliferation
21. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
22. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukaemia
23. Rapid detection of DNA sequence variants by conformation sensitive capillary electrophoresis
24. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein